MAYNE PHARMA GROUP LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.37 AUD | +5.14% |
|
+6.35% | +19.84% |
| Feb. 26 | Mayne Pharma Group Swings to Loss in Fiscal H1 Despite Revenue Growth; Shares Jump 15% | MT |
| Feb. 25 | Transcript : Mayne Pharma Group Limited, H1 2024 Earnings Call, Feb 26, 2024 |
Evolution of the average Target Price on Mayne Pharma Group Limited
Price target over the last 5 years
History of analyst recommendation changes
5507fabb09ab2374c0a7d3c3f7792e.3VAorcUp5dJ4qm8w47fMpVMfHQgmur8Re17r9fROfSU.7whQ_atqkpUI4xZTqMeY7R0ubE4L7tQpKgyJtrk3BUilGFiesBnIihL8Ww~77bea3f8de663fe6fb311eedc75c8a10
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
7.37
AUD
Average target price
7.035
AUD
Spread / Average Target
-4.55%
High Price Target
7.38
AUD
Spread / Highest target
+0.14%
Low Price Target
6.69
AUD
Spread / Lowest Target
-9.23%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
B-
EPS Revisions
- Stock Market
- Equities
- MYX Stock
- Consensus Mayne Pharma Group Limited
